ALDH1 as a CSC marker increases the capacity of cell proliferation and invasion; therefore, ALDH1-positive patients are associated with greater depth of invasion, lymph node metastasis, and poor differentiation, which may reflect the biological behavior of tumors. The gene discussed is ALDH1A1; the disease is metastatic malignant neoplasm in the lymph nodes.